Cargando…
The expanding role of lipoprotein apheresis in the treatment of raised lipoprotein(a) in ischaemic heart disease and refractory angina
It is increasingly recognised that lipoprotein(a) [Lp(a)], an inherited, genetically-determined form of LDL-cholesterol, is an independent cardiovascular risk factor and predictor of adverse cardiovascular outcomes. Lp(a) is felt to increase cardiovascular risk via its pro-thrombotic effect and by e...
Autores principales: | Khan, Tina Z, Pottle, Alison, Pennell, Dudley J, Barbir, Mahmoud S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bloomsbury Qatar Foundation Journals
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104372/ https://www.ncbi.nlm.nih.gov/pubmed/25054114 http://dx.doi.org/10.5339/gcsp.2014.3 |
Ejemplares similares
-
Use of CMR imaging to assess the effect of lipoprotein apheresis in patients with refractory angina and raised lipoprotein(a)
por: Khan, Tina, et al.
Publicado: (2015) -
High prevalence of raised lipoprotein(a) in patients with refractory angina
por: Khan, Tina Z, et al.
Publicado: (2015) -
Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)
por: Khan, Tina Z., et al.
Publicado: (2021) -
Familial Hypercholesterolemia and Lipoprotein Apheresis
por: Makino, Hisashi, et al.
Publicado: (2019) -
Current Role of Lipoprotein Apheresis
por: Thompson, Gilbert, et al.
Publicado: (2019)